| BAY 61-3606 |
ENSG00000100181.17 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000104691.10 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000118412.8 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000124915.6 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000152487.6 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000152487.6 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000163597.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000174365.15 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000175699.8 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000175772.10 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000177406.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000178193.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000178803.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000178977.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000178977.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000179141.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000179219.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000179219.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000179406.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000179859.7 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000180279.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000180712.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000180769.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000181097.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000182376.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000182648.7 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000184068.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000185044.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000185203.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000185904.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000186019.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000186056.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000186056.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000188185.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000188424.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000188660.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000188660.3 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000196756.7 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000196951.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000197332.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000198468.3 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000203325.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000203327.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000203327.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000203362.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000203496.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000203497.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000203499.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000203588.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000203808.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000203875.6 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000203875.6 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000203971.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000203999.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000204055.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000204055.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000204528.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000204791.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000204837.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000204860.4 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000204934.6 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000205037.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000205037.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000205054.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000205181.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000205266.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000205488.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000205562.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000205663.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000205890.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000205913.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000206028.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000206114.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000206142.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000206142.5 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000206142.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000206195.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000206573.4 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000212163.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000213904.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000213994.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000213994.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000214347.5 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000214347.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000214407.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000214772.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000214772.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000214773.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000214837.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000214894.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000214955.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000215039.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000215068.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000215190.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000215256.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000215256.3 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000215386.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000215386.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000215483.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000215498.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000215841.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000219665.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000219665.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000220161.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000223356.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000223380.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000223442.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000223461.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000223475.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000223475.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000223552.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000223571.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000223571.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000223598.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000223685.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000223685.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000223695.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000223725.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000223725.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000223759.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000223759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000223784.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000223797.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000223855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000223872.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000223969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000223975.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000224034.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000224043.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000224057.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000224078.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000224079.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000224157.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000224189.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000224238.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000224356.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000224424.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000224441.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000224490.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000224509.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000224559.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000224592.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000224596.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000224616.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000224635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000224660.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000224671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000224699.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000224713.3 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000224764.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000224789.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000224790.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000224863.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000224884.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000224884.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000224914.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000224933.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000224934.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000224959.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000225030.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000225032.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000225032.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000225037.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000225057.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000225064.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000225075.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000225087.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000225092.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000225111.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000225111.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000225138.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000225163.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000225173.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000225177.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000225177.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000225195.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000225210.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000225218.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000225235.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000225255.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000225311.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000225335.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000225335.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000225393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000225393.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000225434.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000225434.2 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000225439.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000225465.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000225518.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000225555.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000225555.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000225643.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000225647.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000225675.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000225703.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000225703.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000225767.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000225839.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000225857.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000225857.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000225963.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000226026.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000226031.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000226067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000226137.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000226179.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000226200.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000226266.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000226281.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000226380.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000226381.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000226383.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000226419.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000226445.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000226505.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000226562.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000226609.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000226609.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000226629.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000226637.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000226649.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000226659.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000226711.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000226711.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000226738.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000226756.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000226824.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000226824.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000226833.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000226842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000226853.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000226864.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000226876.2 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000226890.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000226904.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000226920.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000226954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000226969.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000227006.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000227028.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000227070.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000227110.2 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000227186.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000227195.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000227214.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000227237.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000227256.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000227256.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000227285.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000227359.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000227431.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000227456.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000227486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000227495.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000227516.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000227527.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000227542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000227544.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000227579.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000227603.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000227637.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000227676.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000227678.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000227680.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000227681.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000227698.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000227702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000227719.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000227740.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000227811.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000227848.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000227885.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000227885.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000227888.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000227895.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000227896.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000227946.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000227953.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000227959.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000228028.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000228028.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000228065.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000228109.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000228140.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000228242.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000228274.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000228290.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000228294.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000228315.7 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000228323.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000228327.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000228327.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000228340.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000228352.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000228353.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000228369.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000228412.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000228437.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000228463.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000228485.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000228509.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000228554.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000228614.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000228614.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000228629.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000228630.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000228649.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000228649.4 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000228677.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000228679.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000228686.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000228701.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000228748.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000228775.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000228791.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000228824.2 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000228826.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000228857.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000228857.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000228906.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000229153.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000229162.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000229203.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000229227.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000229327.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000229348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000229348.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000229379.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000229382.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000229487.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000229558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000229628.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000229656.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000229688.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000229728.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000229821.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000229832.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000229832.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000229848.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000229867.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000229873.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000229931.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000229951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000229980.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000229989.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000229999.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000230002.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000230010.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000230061.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000230140.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000230155.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000230177.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000230212.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000230212.2 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000230289.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000230289.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000230345.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000230400.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000230408.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000230479.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000230487.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000230487.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000230550.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000230555.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000230612.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000230613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000230641.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000230735.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000230736.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000230753.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000230790.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000230806.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000230836.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000230838.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000230844.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000230850.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000230850.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000230896.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000230925.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000230978.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000231028.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000231064.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000231154.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000231156.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000231187.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000231196.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000231226.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000231227.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000231242.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000231298.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000231305.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000231459.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000231536.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000231595.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000231607.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000231609.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000231652.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000231663.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000231663.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000231709.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000231734.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000231742.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000231789.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000231830.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000231840.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000231842.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000231851.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000231871.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000231903.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000231908.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000231927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000231966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000231999.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000231999.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000232021.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000232065.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000232065.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000232098.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000232116.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000232124.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000232233.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000232300.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000232316.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000232325.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000232386.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000232401.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000232401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000232406.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000232406.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000232412.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000232445.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000232445.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000232453.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000232455.2 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000232470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000232470.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000232485.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000232490.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000232527.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000232533.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000232555.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000232600.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000232611.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000232633.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000232677.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000232693.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000232698.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000232710.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000232719.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000232725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000232762.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000232912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000232931.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000232936.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000232949.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000232949.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000232956.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000232973.7 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000233030.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000233058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000233069.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000233077.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000233081.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000233117.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000233144.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000233144.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000233230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000233237.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000233244.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000233246.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000233296.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000233296.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000233330.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000233330.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000233355.2 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000233360.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000233411.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000233411.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000233429.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000233452.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000233483.2 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000233496.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000233602.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000233639.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000233654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000233694.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000233757.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000233757.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000233776.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000233783.3 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000233783.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000233799.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000233818.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000233847.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000233847.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000233871.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000233953.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000233967.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000233977.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000234072.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000234084.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000234160.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000234174.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000234185.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000234235.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000234245.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000234264.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000234327.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000234350.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000234393.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000234405.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000234432.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000234478.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000234494.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000234503.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000234509.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000234571.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000234584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000234630.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000234695.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000234705.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000234705.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000234718.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000234753.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000234789.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000234789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000234789.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000234817.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000234817.2 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000234869.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000234880.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000234902.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000234915.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000234936.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000234945.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000234945.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000234945.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000234978.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000234996.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000235021.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000235078.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000235117.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000235180.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000235189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000235214.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000235244.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000235246.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000235269.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000235271.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000235293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000235326.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000235358.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000235423.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000235423.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000235445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000235477.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000235481.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000235530.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000235597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000235609.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000235621.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000235629.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000235664.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000235760.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000235770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000235781.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000235781.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000235790.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000235830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000235837.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000235848.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000235890.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000235910.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000235910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000235927.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000235927.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000235954.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000235989.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000236016.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000236066.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000236066.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000236098.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000236255.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000236256.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000236337.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000236347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000236366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000236449.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000236452.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000236457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000236498.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000236526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000236528.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000236540.3 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000236540.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000236643.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000236651.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000236703.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000236714.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000236753.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000236760.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000236799.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000236833.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000236850.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000236861.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000236861.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000236861.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000236889.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000236935.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000236936.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000237015.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000237021.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000237037.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000237073.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000237073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000237133.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000237152.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000237200.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000237399.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000237399.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000237424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000237436.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000237438.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000237481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000237505.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000237595.2 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000237609.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000237685.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000237697.2 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000237697.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000237751.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000237753.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000237756.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000237756.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000237772.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000237805.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000237807.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000237819.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000237853.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000237903.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000237934.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000237938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000237945.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000237950.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000237976.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000237976.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000237980.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000237998.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000238045.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000238057.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000238062.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000238120.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000238120.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000238121.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000238133.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000238133.2 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000238141.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000238197.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000238198.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000238221.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000238221.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000238221.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000238260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000238266.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000238279.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000238287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000238287.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000238290.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000238755.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000239002.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000239002.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000239002.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000239213.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000239219.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000239335.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000239377.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000239552.2 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000239552.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000239653.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000239774.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000240093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000240137.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000240288.3 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000240291.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000240440.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000240440.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000240498.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000240499.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000240549.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000240770.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000240875.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000240915.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000240922.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000241014.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000241269.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000241570.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000241818.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000242086.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000242094.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000242190.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000242268.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000242474.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000242622.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000242759.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000242791.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000242791.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000242798.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000243368.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000243433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000243533.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000243766.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000243819.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000243849.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000243960.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000244124.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000244161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000244198.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000244198.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000244265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000244306.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000244332.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000244332.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000244349.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000244380.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000244393.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000244479.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000244479.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000244479.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000244649.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000244879.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000244926.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000244945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000245105.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000245105.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000245146.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000245498.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000245598.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000245598.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000245614.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000245748.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000246090.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000246308.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000246323.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000246339.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000246379.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000246451.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000246740.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000246777.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000246790.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000246792.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000246898.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000246898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000247081.3 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000247213.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000247363.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000247373.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000247498.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000247675.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000247679.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000247679.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000247708.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000247735.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000247765.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000247877.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000248019.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000248092.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000248103.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000248125.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000248202.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000248206.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000248265.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000248275.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000248416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000248416.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000248429.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000248494.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000248494.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000248508.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000248514.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000248538.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000248714.2 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000248734.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000248752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000248774.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000248787.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000248864.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000248866.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000248932.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000248936.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000249082.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000249084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000249249.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000249252.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000249304.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000249307.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000249348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000249359.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000249378.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000249379.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000249379.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000249412.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000249417.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000249476.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000249502.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000249637.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000249655.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000249684.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000249737.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000249740.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000249825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000249859.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000249870.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000249996.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000250033.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000250069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000250075.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000250132.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000250155.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000250222.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000250222.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000250260.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000250267.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000250282.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000250282.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000250286.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000250295.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000250312.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000250320.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000250326.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000250409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000250421.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000250451.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000250548.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000250584.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000250734.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000250740.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000250742.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000250765.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000250790.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000250820.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000250842.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000250893.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000250899.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000250900.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000250903.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000250948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000250988.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000250994.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000251003.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000251018.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000251023.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000251072.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000251136.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000251136.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000251136.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000251151.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000251164.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000251191.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000251221.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000251273.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000251281.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000251292.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000251301.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000251307.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000251323.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000251330.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000251387.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000251388.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000251414.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000251417.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000251455.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000251455.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000251459.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000251497.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000251513.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000251562.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000251598.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000251604.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000251615.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000251623.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000251687.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000253121.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000253121.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000253210.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000253266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000253302.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000253327.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000253385.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000253519.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000253530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000253549.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000253603.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000253641.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000253641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000253669.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000253686.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000253701.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000253736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000253737.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000253744.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000253829.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000253865.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000253930.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000253948.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000253961.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000254027.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000254034.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000254057.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000254084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000254099.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000254142.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000254162.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000254162.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000254162.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000254204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000254258.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000254263.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000254267.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000254341.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000254341.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000254341.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000254353.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000254389.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000254397.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000254409.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000254409.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000254414.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000254510.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000254664.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000254664.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000254664.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000254694.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000254694.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000254739.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000254791.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000254821.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000254847.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000254869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000254900.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000254910.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000254910.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000254966.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000254991.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000255045.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000255045.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000255050.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000255079.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000255092.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000255094.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000255118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000255145.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000255158.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000255198.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000255236.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000255237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000255241.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000255250.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000255276.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000255276.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000255322.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000255328.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000255343.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000255343.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000255348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000255455.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000255474.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000255474.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000255507.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000255557.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000255670.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000255790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000255920.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000255946.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000255966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000255980.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000256006.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000256050.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000256092.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000256116.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000256128.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000256164.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000256196.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000256196.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000256196.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000256248.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000256443.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000256452.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000256458.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000256538.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000256564.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000256712.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000256712.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000256746.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000256789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000256973.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000257058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000257135.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000257139.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000257176.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000257183.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000257193.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000257219.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000257261.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000257264.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000257270.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000257298.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000257337.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000257354.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000257381.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000257381.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000257391.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000257443.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000257452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000257475.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000257488.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000257496.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000257507.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000257527.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000257563.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000257595.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000257596.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000257596.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000257642.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000257740.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000257815.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000257829.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000257829.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000257891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000257904.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000257913.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000257925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000257931.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000257964.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000258010.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000258077.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000258082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000258088.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000258096.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000258099.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000258181.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000258265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000258274.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000258301.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000258302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000258314.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000258323.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000258325.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000258334.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000258344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000258354.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000258400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000258413.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000258424.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000258428.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000258454.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000258471.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000258520.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000258537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000258580.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000258731.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000258733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000258777.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000258809.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000258811.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000258821.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000258884.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000258914.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000258920.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000258920.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000258927.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000258929.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000258929.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000258929.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000258938.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000258976.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000258982.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000259017.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000259023.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000259038.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000259038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000259038.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259116.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259125.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000259187.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259201.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259206.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259212.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000259212.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259212.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000259212.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000259306.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259310.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259380.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000259410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000259418.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000259418.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000259426.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000259438.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000259442.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259442.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000259469.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000259473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000259476.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000259488.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000259590.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000259604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000259606.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000259617.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000259623.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259644.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000259645.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000259668.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259700.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000259701.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259714.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000259723.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000259727.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000259732.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259736.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259736.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000259758.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000259762.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000259783.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259791.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000259793.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259797.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259804.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000259818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000259818.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000259920.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000259921.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259926.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000259935.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259953.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000259969.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000260000.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260017.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000260018.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000260038.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000260060.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000260060.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260060.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260088.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260088.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000260093.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000260101.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000260132.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000260137.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260156.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000260167.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000260173.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260177.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260186.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000260190.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260190.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000260194.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000260269.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000260273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260278.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000260285.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260285.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260288.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260296.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000260366.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260369.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000260400.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000260409.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000260409.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260411.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000260423.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260425.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000260430.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260475.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260495.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000260495.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260496.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260515.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000260523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000260552.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000260578.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000260589.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000260591.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000260593.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260601.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000260612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260626.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260635.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260645.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000260648.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000260657.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000260657.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260660.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000260660.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000260664.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260735.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260757.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000260792.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000260796.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260804.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000260807.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000260814.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260816.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000260834.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000260855.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000260874.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000260877.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260907.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260918.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000260924.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000260931.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000260932.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000260941.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000260949.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000260954.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000260978.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000260988.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261000.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000261002.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261002.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261008.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000261064.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000261068.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261068.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000261069.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000261092.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000261096.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000261105.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000261140.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000261168.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000261186.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000261187.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000261187.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261188.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000261193.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000261204.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000261207.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000261216.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261251.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000261252.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000261266.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000261318.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000261326.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261341.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261342.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000261360.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000261386.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000261396.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000261404.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261416.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261423.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000261428.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000261428.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261430.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000261431.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000261455.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000261455.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261488.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261505.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000261521.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000261529.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000261537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000261544.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261560.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000261570.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000261574.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000261584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000261589.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000261589.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261610.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000261618.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000261634.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000261646.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261654.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000261654.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000261663.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261692.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000261693.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000261716.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000261731.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000261744.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000261754.2 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000261757.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000261757.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261773.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000261783.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000261783.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000261801.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000261801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000261823.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000261838.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000261889.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000261971.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000261996.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000262094.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000262115.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000262165.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000262171.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000262185.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000262194.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000262296.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000262319.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000262339.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000262514.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000262558.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000262585.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000262652.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000262703.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000262810.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000262815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000262833.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000262833.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000262837.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000262873.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000262877.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000262903.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000262973.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000263004.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000263050.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000263105.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000263214.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000263257.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000263327.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000263338.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000263345.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000263345.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000263370.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000263412.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000263466.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000263520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000263531.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000263603.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000263624.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000263657.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000263727.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000263731.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000263753.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000263753.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000263786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000263859.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000263916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000263975.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000263982.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000264043.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000264112.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000264125.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000264188.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000264222.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000264270.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000264304.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000264339.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000264365.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000264448.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000264456.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000264456.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000264469.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000264486.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000264513.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000264577.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000264647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000264769.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000264808.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000264829.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000264920.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000264937.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000264940.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000264968.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000265204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000265218.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000265334.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000265413.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000265688.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000265728.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000265739.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000265787.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000265791.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000266010.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000266079.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000266120.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000266236.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000266236.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000266289.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000266289.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000266304.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000266340.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000266340.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000266385.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000266401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000266402.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000266411.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000266445.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000266602.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000266667.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000266677.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000266709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000266821.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000266850.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000266901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000266911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000266918.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000266926.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000266930.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000266930.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000266933.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000266936.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000266941.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000266983.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000266993.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000267003.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267003.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000267006.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000267011.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267016.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000267018.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000267018.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000267024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267026.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000267026.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267040.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267040.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267058.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267080.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267082.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000267093.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000267104.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000267108.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267123.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267130.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267136.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000267141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000267141.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000267161.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000267175.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000267192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000267194.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000267207.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267213.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000267219.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267221.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000267222.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000267249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000267249.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267254.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000267255.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000267273.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000267277.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000267278.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267296.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267316.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267321.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267321.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267327.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000267366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000267383.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000267416.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000267474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000267480.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267480.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267491.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000267502.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000267510.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267510.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267522.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267529.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000267543.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000267567.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267567.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000267651.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000267655.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000267659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000267662.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000267677.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267682.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000267682.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000267702.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000267730.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000267750.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000267751.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267765.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267778.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267898.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000267905.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000268051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000268093.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000268093.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000268095.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000268199.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000268201.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000268204.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000268204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000268205.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000268307.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000268307.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000268307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000268340.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000268340.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000268340.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000268340.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000268520.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000268536.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000268543.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000268549.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000268564.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000268568.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000268568.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000268584.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000268686.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000268756.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000268764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000268889.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000268945.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000269051.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000269161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000269194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000269235.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000269235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000269246.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000269246.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000269321.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000269352.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000269444.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000269463.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000269480.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000269483.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000269487.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000269680.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000269688.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000269814.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000269867.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000269895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000269898.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000269906.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000269918.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000269925.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000269942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000269946.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000269946.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000269951.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000269956.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000269978.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000269980.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000269983.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000269983.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000270006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000270018.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000270031.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000270052.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000270060.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000270067.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000270095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000270095.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000270109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000270109.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000270116.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000270130.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000270130.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000270133.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000270133.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000270133.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000270137.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000270143.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000270145.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000270145.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000270154.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000270159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000270159.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000270170.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000270174.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000270177.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000270189.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000270190.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000270195.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000270361.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000270460.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000270604.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000270605.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000270673.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000270673.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000270681.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000270720.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000270760.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000270876.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000270933.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000270951.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000271032.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000271119.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000271127.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000271127.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000271133.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000271147.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000271200.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000271204.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000271218.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000271270.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000271327.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000271367.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000271384.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000271387.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000271387.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000271390.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000271398.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000271538.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000271584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000271631.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000271659.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000271716.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000271755.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000271757.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000271757.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000271778.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000271781.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000271781.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000271782.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000271782.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000271788.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000271788.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000271788.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000271788.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000271788.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000271857.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000271862.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000271882.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000271912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000271913.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000271926.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000271967.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000271971.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000271975.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000271978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000271983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000271992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000271993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272009.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000272009.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272043.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272049.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272076.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272077.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272077.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272077.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272088.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272092.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272121.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272121.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272128.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272128.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272143.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272144.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272156.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272183.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000272205.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272209.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000272209.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272209.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272216.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000272219.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272226.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000272255.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000272255.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272255.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000272263.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272320.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272335.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000272338.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272341.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000272343.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000272346.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272354.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000272360.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000272369.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000272371.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000272374.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272389.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272420.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272425.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000272426.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000272428.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272432.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272452.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000272482.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272489.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000272498.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000272498.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272505.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272508.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000272508.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272508.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000272524.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272524.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272525.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272556.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272567.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272567.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272604.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272604.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272604.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272622.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272631.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000272639.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272659.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000272660.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272666.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000272699.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272707.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272716.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272720.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272744.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000272744.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272744.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272746.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000272754.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000272755.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272763.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000272764.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272788.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000272792.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272812.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272829.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272834.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000272848.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000272849.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000272859.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000272859.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000272862.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000272864.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000272864.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272872.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272892.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| BAY 61-3606 |
ENSG00000272904.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272917.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272917.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000272942.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000272953.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000272954.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000272960.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272977.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272984.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000272989.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000272993.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000272995.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000273002.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273007.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273017.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000273019.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000273056.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000273065.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000273065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000273065.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273073.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273073.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273081.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000273097.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000273132.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000273176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000273177.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000273190.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000273216.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273218.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000273233.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000273237.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000273240.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000273243.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| BAY 61-3606 |
ENSG00000273249.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000273249.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000273270.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000273270.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273272.1 |
Predicted lncRNA |
Sarcoma |
|
| BAY 61-3606 |
ENSG00000273281.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273290.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000273297.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000273302.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000273307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000273319.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| BAY 61-3606 |
ENSG00000273329.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273338.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000273348.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000273355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| BAY 61-3606 |
ENSG00000273365.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000273369.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273373.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273374.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273403.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| BAY 61-3606 |
ENSG00000273424.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| BAY 61-3606 |
ENSG00000273424.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| BAY 61-3606 |
ENSG00000273449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| BAY 61-3606 |
ENSG00000273473.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000273486.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| BAY 61-3606 |
ENSG00000273488.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| BAY 61-3606 |
ENSG00000273492.1 |
Predicted lncRNA |
Esophageal cancer |
|
| BAY 61-3606 |
ENSG00000273493.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
